Pricing and market access strategy for a haematology product in the GCC
Client Situation
Our client has a sickle disease portfolio and wanted to understand how to optimally launch in GCC markets through understanding price potential and feasibility of innovative contracting in order to boost patient access.
Project Scope
To understand price potential for a sickle cell disease product in GCC markets
In depth secondary research was conducted focusing on understanding the prevalence of sickle cell disease, patient journey and competitor products
Conducted primary research consisting of qualitative and quantitative discussions to understand the nuances within the sickle cell disease landscape across key geographies
Tested the price and access potential of the novel therapeutic agent
Results
Successfully enabled our client to develop localised contracts and access strategy in each key market
Recommended optimal launch sequence to manage price referencing risks